Prolonged survival after disseminated Rhinocladiella infection treated with surgical excision and posaconazole

Nicola Hardman1, Nicola Young1, Richard Hobson1

  • 1Department of Microbiology, Leeds Teaching Hospitals Trust, Leeds, UK.

Insights

A rare brain infection caused by the mold Rhinocladiella mackenziei in a transplant patient was successfully treated with a novel antifungal combination. Beta-D-glucan levels effectively monitored the patient's response over five years.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Neurosurgery

Background:

  • Pigmented mold infections, such as cerebral abscesses, are rare and often fatal, particularly in immunocompromised individuals like transplant recipients.
  • Rhinocladiella mackenziei is an emerging fungal pathogen causing opportunistic infections.

Observation:

  • A 67-year-old renal transplant recipient developed a cerebral abscess and septic arthritis caused by Rhinocladiella mackenziei.
  • The infection disseminated to both the brain and ankle, presenting a complex clinical challenge.

Findings:

  • The patient was treated with a multi-year regimen including voriconazole, liposomal amphotericin B, and a novel combination of posaconazole and flucytosine.
  • Cerebral lesion stabilization and a favorable outcome were achieved with the novel antifungal combination.
  • Elevated Beta-D-glucan levels served as a reliable biomarker for monitoring treatment response over five years, eventually becoming negative.

Implications:

  • This case highlights the first reported disseminated Rhinocladiella mackenziei infection with a favorable outcome.
  • The successful use of a novel antifungal combination offers a potential new treatment strategy for such infections.
  • The utility of Beta-D-glucan monitoring in managing disseminated fungal infections is demonstrated.